Chemotherapy for osteosarcoma – Where does it come from? What is it? Where is it going?

Results of a Sarcoma Alliance for Research through Collaboration (SARC) phase II trial of dasatinib in previously treated, high-grade, advanced sarcoma.

(2017) S. Schuetze et al.   JOURNAL OF CLINICAL ONCOLOGY

Extraskeletal Osteosarcoma of the Breast in an Adolescent Girl

(2013) Katja Zils et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

Extraskeletal osteosarcoma of penis: A case report

(2012) Chuan-zhen Wu et al.   Chinese Journal of Cancer Research

A phase II trial of second-line pemetrexed in adults with advanced/metastatic osteosarcoma

(2012) Florence Duffaud et al.   EUROPEAN JOURNAL OF CANCER

Insulin-like growth factor type 1 receptor (IGF-1R) exclusive nuclear staining: A predictive biomarker for IGF-1R monoclonal antibody (Ab) therapy in sarcomas

(2012) Irène Asmane et al.   EUROPEAN JOURNAL OF CANCER

Phase II Trial of Trastuzumab in Combination With Cytotoxic Chemotherapy for Treatment of Metastatic Osteosarcoma With Human Epidermal Growth Factor Receptor 2 Overexpression: A Report From the Children's Oncology Group

(2012) David Ebb et al.   JOURNAL OF CLINICAL ONCOLOGY

Molecular alterations as target for therapy in metastatic osteosarcoma: a review of literature

(2011) J. PosthumaDeBoer et al.   CLINICAL & EXPERIMENTAL METASTASIS

Phase I/II Trial and Pharmacokinetic Study of Cixutumumab in Pediatric Patients With Refractory Solid Tumors and Ewing Sarcoma: A Report From the Children's Oncology Group

(2011) Suman Malempati et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase II study of gemcitabine combined with oxaliplatin in relapsed or refractory paediatric solid malignancies: An innovative therapy for children with Cancer European Consortium Study

(2010) Birgit Geoerger et al.   EUROPEAN JOURNAL OF CANCER

Rexin-G, a targeted genetic medicine for cancer

(2010) Erlinda M Gordon et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Phase II Multicenter Trial of Imatinib in 10 Histologic Subtypes of Sarcoma Using a Bayesian Hierarchical Statistical Model

(2009) Rashmi Chugh et al.   JOURNAL OF CLINICAL ONCOLOGY

Multiinstitutional phase II study of neoadjuvant chemotherapy for osteosarcoma (NECO study) in Japan: NECO-93J and NECO-95J

(2009) Yukihide Iwamoto et al.   JOURNAL OF ORTHOPAEDIC SCIENCE

Phase I/II and Phase II Studies of Targeted Gene Delivery In Vivo: Intravenous Rexin-G for Chemotherapy-resistant Sarcoma and Osteosarcoma

(2009) Sant P Chawla et al.   MOLECULAR THERAPY

Pediatric Phase I and Pharmacokinetic Study of Erlotinib Followed by the Combination of Erlotinib and Temozolomide: A Children's Oncology Group Phase I Consortium Study

(2008) Regina I. Jakacki et al.   JOURNAL OF CLINICAL ONCOLOGY